GitLab (GTLB) Financial statements
Company Profile
| Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | ||
|---|---|---|---|---|---|
| Total Revenue | |||||
| Cost of Revenue | |||||
| Gross Profit | |||||
| Gross Profit Margin (%) | |||||
| R&D Expense | |||||
| SG&A Expense | |||||
| Total Operating Expenses | |||||
| Operating Income or Loss | |||||
| Operating Margin (%) | |||||
| Interest Expense | |||||
| Total Other Income/Expenses | |||||
| Income Before Tax | |||||
| Income Tax Expense | |||||
| Income from Continuing Ops. | |||||
| Net Income | |||||
| Net Profit Margin (%) | |||||
| Net Income Available to Common Shareholders | |||||
| Basic EPS | |||||
| Diluted EPS | |||||
| Basic Average Shares | |||||
| Diluted Average Shares |
| Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 | Jul 2023 | Apr 2023 | Jan 2023 | Oct 2022 | Jul 2022 | Apr 2022 | Jan 2022 | Oct 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||||||||||||
| Cost of Revenue | |||||||||||||||||
| Gross Profit | |||||||||||||||||
| Gross Profit Margin (%) | |||||||||||||||||
| R&D Expense | |||||||||||||||||
| SG&A Expense | |||||||||||||||||
| Total Operating Expenses | |||||||||||||||||
| Operating Income or Loss | |||||||||||||||||
| Operating Margin (%) | |||||||||||||||||
| Interest Expense | |||||||||||||||||
| Total Other Income/Expenses | |||||||||||||||||
| Income Before Tax | |||||||||||||||||
| Income Tax Expense | |||||||||||||||||
| Income from Continuing Ops. | |||||||||||||||||
| Net Income | |||||||||||||||||
| Net Profit Margin (%) | |||||||||||||||||
| Net Income Available to Common Shareholders | |||||||||||||||||
| Basic EPS | |||||||||||||||||
| Diluted EPS | |||||||||||||||||
| Basic Average Shares | |||||||||||||||||
| Diluted Average Shares |
| Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | ||
|---|---|---|---|---|---|
| Current Assets | |||||
| Cash & Cash Equivalents | |||||
| Marketable Securities | |||||
| Receivables | |||||
| Inventories | |||||
| Other Current Assets | |||||
| Total Current Assets | |||||
| Non-Current Assets | |||||
| Marketable Securities | |||||
| PPE Net | |||||
| Intangibles inc. Goodwill | |||||
| Other Non-Current Assets | |||||
| Total Non-Current Assets | |||||
| Total Assets | |||||
| Current Liabilities | |||||
| Accounts Payable | |||||
| Deferred Revenues | |||||
| Debt, Current | |||||
| Accrued Liabilities | |||||
| Other Current Liabilities | |||||
| Total Current Liabilities | |||||
| Non-Current Liabilities | |||||
| Deferred Revenues | |||||
| Debt, Non-Current | |||||
| Other Non-Current Liabilities | |||||
| Total Non-Current Liabilities | |||||
| Total Liabilities | |||||
| Shareholders' Equity | |||||
| Common Stock | |||||
| Additional Paid-In Capital | |||||
| Retained Earnings | |||||
| Other Shareholders' Equity | |||||
| Total Shareholders' Equity | |||||
| Total Liabilities & Shareholders' Equity |
| Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 | Jul 2023 | Apr 2023 | Jan 2023 | Oct 2022 | Jul 2022 | Apr 2022 | Jan 2022 | Oct 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | |||||||||||||||||
| Cash & Cash Equivalents | |||||||||||||||||
| Marketable Securities | |||||||||||||||||
| Receivables | |||||||||||||||||
| Inventories | |||||||||||||||||
| Other Current Assets | |||||||||||||||||
| Total Current Assets | |||||||||||||||||
| Non-Current Assets | |||||||||||||||||
| Marketable Securities | |||||||||||||||||
| PPE Net | |||||||||||||||||
| Intangibles inc. Goodwill | |||||||||||||||||
| Other Non-Current Assets | |||||||||||||||||
| Total Non-Current Assets | |||||||||||||||||
| Total Assets | |||||||||||||||||
| Current Liabilities | |||||||||||||||||
| Accounts Payable | |||||||||||||||||
| Deferred Revenues | |||||||||||||||||
| Debt, Current | |||||||||||||||||
| Accrued Liabilities | |||||||||||||||||
| Other Current Liabilities | |||||||||||||||||
| Total Current Liabilities | |||||||||||||||||
| Non-Current Liabilities | |||||||||||||||||
| Deferred Revenues | |||||||||||||||||
| Debt, Non-Current | |||||||||||||||||
| Other Non-Current Liabilities | |||||||||||||||||
| Total Non-Current Liabilities | |||||||||||||||||
| Total Liabilities | |||||||||||||||||
| Shareholders' Equity | |||||||||||||||||
| Common Stock | |||||||||||||||||
| Additional Paid-In Capital | |||||||||||||||||
| Retained Earnings | |||||||||||||||||
| Other Shareholders' Equity | |||||||||||||||||
| Total Shareholders' Equity | |||||||||||||||||
| Total Liabilities & Shareholders' Equity |
| Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | ||
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net Income | |||||
| Depreciation & Amortization | |||||
| Deferred Income Taxes | |||||
| Stock Based Compensation | |||||
| Accounts Receivable | |||||
| Inventory | |||||
| Accounts Payable | |||||
| Deferred Revenue | |||||
| Other Non-Cash | |||||
| Operating Cash Flow | |||||
| Cash Flows from Investing Activities | |||||
| PPE Investments | |||||
| Net Acquisitions | |||||
| Purchase of Investments | |||||
| Sale of Investments | |||||
| Other Investing Activity | |||||
| Investing Cash Flow | |||||
| Cash Flows from Financing Activities | |||||
| Debt Issued | |||||
| Proceeds from Debt Repayment | |||||
| Debt Repayment | |||||
| Proceeds from Sale of Equity | |||||
| Equity Repurchased | |||||
| Dividend Paid | |||||
| Other Financing Activity | |||||
| Financing Cash Flow | |||||
| Cash Position | |||||
| Beginning Cash Position | |||||
| End Cash Position | |||||
| Change in Cash | |||||
| Free Cash Flow | |||||
| Operating Cash Flow | |||||
| Capital Expenditure | |||||
| Free Cash Flow |
| Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 | Jul 2023 | Apr 2023 | Jan 2023 | Oct 2022 | Jul 2022 | Apr 2022 | Jan 2022 | Oct 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||||||||||||||
| Net Income | |||||||||||||||||
| Depreciation & Amortization | |||||||||||||||||
| Deferred Income Taxes | |||||||||||||||||
| Stock Based Compensation | |||||||||||||||||
| Accounts Receivable | |||||||||||||||||
| Inventory | |||||||||||||||||
| Accounts Payable | |||||||||||||||||
| Deferred Revenue | |||||||||||||||||
| Other Non-Cash | |||||||||||||||||
| Operating Cash Flow | |||||||||||||||||
| Cash Flows from Investing Activities | |||||||||||||||||
| PPE Investments | |||||||||||||||||
| Net Acquisitions | |||||||||||||||||
| Purchase of Investments | |||||||||||||||||
| Sale of Investments | |||||||||||||||||
| Other Investing Activity | |||||||||||||||||
| Investing Cash Flow | |||||||||||||||||
| Cash Flows from Financing Activities | |||||||||||||||||
| Debt Issued | |||||||||||||||||
| Proceeds from Debt Repayment | |||||||||||||||||
| Debt Repayment | |||||||||||||||||
| Proceeds from Sale of Equity | |||||||||||||||||
| Equity Repurchased | |||||||||||||||||
| Dividend Paid | |||||||||||||||||
| Other Financing Activity | |||||||||||||||||
| Financing Cash Flow | |||||||||||||||||
| Cash Position | |||||||||||||||||
| Beginning Cash Position | |||||||||||||||||
| End Cash Position | |||||||||||||||||
| Change in Cash | |||||||||||||||||
| Free Cash Flow | |||||||||||||||||
| Operating Cash Flow | |||||||||||||||||
| Capital Expenditure | |||||||||||||||||
| Free Cash Flow |